Novo Nordisk reported DKK4.74 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 4.74 5.14 5.96 Aug/05
FY2026Q1 Mar/2026 10.91 5.86 6.53 May/06
FY2025Q4 Dec/2025 6.04 5.89 6.34 Feb/04
FY2025Q3 Sep/2025 4.50 5.52 6.12 Sep/26
FY2025Q2 Jun/2025 5.96 6.00 4.49 Aug/06




Eps Change Date
Bausch Health Companies USD 1.77 0.51 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Novo Nordisk DKK 0.96 9.95 Jun/2026
Pacira USD 0.7 0.03 Sep/2026
Sanofi EUR 3.55 1.46 Sep/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026